MedTech Dive February 23, 2024
Nick Paul Taylor

Unauthorized smartwatches and smart rings are “manufactured by dozens of companies and sold under multiple brand names,” according to the agency.

Dive Brief:

  • The Food and Drug Administration warned patients against using smartwatches or smart rings that claim to measure blood sugar without piercing the skin.
  • Officials published the safety notice Wednesday after learning that people are selling wearables that claim to noninvasively monitor blood glucose. The devices are “manufactured by dozens of companies and sold under multiple brand names,” according to the agency.
  • The FDA has never authorized a noninvasive wearable that measures or estimates blood glucose values on its own and is concerned inaccurate readings could lead to errors in the management of diabetes.
...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

Continue Reading

 
Topics: Digital Health, FDA, Govt Agencies, Medical Devices, Technology, Wearables
Related Articles:
FDA Update for Week of April 22, 2024: Second Gene Therapy for Hemophilia B
11 drugs now in shortage
FDA approves Pfizer’s first gene therapy for rare inherited bleeding disorder
Pfizer hemophilia gene therapy arrives in US to uncertain future
Pfizer’s First Gene Therapy Approval Sets Up a Showdown With CSL in Hemophilia B

Share This Article